IgA Nephropathy Optimisation — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Increase ACE inhibitor to maximum tolerated dose, add ARB (dual blockade), and optimise salt restriction before considering immunosuppression
Before starting immunosuppression in IgA nephropathy, supportive measures should be optimised: maximise ACE inhibitor/ARB dose, add the other class (dual RAS blockade with careful monitoring), restrict dietary salt, and control BP. The TESTING and STOP-IgAN trials guide immunosuppressive decisions.
Reference: RCH Melbourne – 2024 – Clinical Practice Guidelines: IgA Nephropathy